Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy

Yonsei University99 enrolled

Overview

Set the Korean Familial Hypertrophic Cardiomyopathy (KFHC) registry to study the prevalence of gene mutations in Korean patients with familial hypertrophic cardiomyopathy

Study Type

OBSERVATIONAL

Enrollment

Conditions

Familial Hypertrophic Cardiomyopathy

Eligibility

Sex: ALLMin age: 13 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. left ventricular maximal wall thickness ≥ 15mm on echocardiography 2. hypertrophic cardiomyopathy patients' relatives Exclusion Criteria: 1. other cardiomyopathy or systemic disease (e.g. fabry disease, danon disease, glycogen storage disease) 2. who deny the study entrance, especially in patients' relatives

Locations (1)

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine

Seoul, Seoul, South Korea

Outcomes

Primary Outcomes

1) DNA analysis

1\) Identify susceptible genes for familial hypertrophic cardiomyopathy in Korean

Time frame: 1 year

Secondary Outcomes

2) Prognosis of familial hypertrophic cariomyopathy

2\) all-cause mortality, hospitalization for heart failure progression, stroke, heart transplantation

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.